Acute intermittent porphyria with peripheral neuropathy complicated by small-fiber neuropathy

Neuropathology

Volumn 27, Issue 2, 2007, Pages 133-138

  Hsieh, Ching Hua ^a   Tsai, Hui Hong ^a   Lu, Tsu Hsiang ^a   Chen, Yi Chun ^a   Hsieh, Min Wei ^a   Chuang, Yao Chung ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Acute intermittent porphyria; Intra epidermal nerve fiber density; Peripheral neuropathy; Protein gene product 9.5; Small fiber neuropathy

Indexed keywords

GENE PRODUCT; UBIQUITIN THIOLESTERASE;

ABDOMINAL PAIN; ACUTE INTERMITTENT PORPHYRIA; ADULT; ARTICLE; CASE REPORT; CELL DENSITY; DISEASE COURSE; EPIDERMIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NERVE FIBER; NEUROLOGIC EXAMINATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PUNCH BIOPSY; QUADRIPLEGIA; RESPIRATORY FAILURE; SKIN BIOPSY; SKIN NERVE; SMALL FIBER NEUROPATHY;

HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; PORPHYRIA, ACUTE INTERMITTENT; QUADRIPLEGIA; RESPIRATORY INSUFFICIENCY; SKIN; UBIQUITIN THIOLESTERASE;

EID: 34147102396     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2006.00751.x     Document Type: Article

References (28)

1. Lip GYH, McColl KEL, Moore MR. The acute porphyries. Br J Clin Pharmacol 1993; 47: 38-43.
2. Herrick AL, McColl KE. Acute intermittent porphyria. Best Pract Res Clin Gastroenterol 2005; 19: 235-249.
3. Ridley A. Porphyric neuropathy. In: Dick PJ, Thomas PK, Lambert EH, Bunge R (eds). Peripheral Neuropathy. Philadelphia: Saunders, 1984; 1704-1716.
4. Black KS, Mirsky P, Kalina P et al. Angiographic demonstration of reversible cerebral vasospasm in porphyric encephalopathy. Am J Neuroradiol 1995; 16: 1650-1652.
5. Suarez JI, Cohen ML, Larkin J, Kernich CA, Hricik DE, Daroff RB. Acute intermittent porphyria: clinicopathologic correlation. Report of a case and review of the literature. Neurology 1997; 48: 1678-1683.
6. Leger JM, Salachas F. Diagnosis of motor neuropathy. Eur J Neurol 2001; 8: 201-208.
7. Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic Basis of Inherited Disease, 7th edn, Vol. 2. New York: McGraw-Hill, 1995; 2103-2160.
8. Sack GH Jr. Acute intermittent porphyria. JAMA 1990; 264: 1290-1293.
9. Sorenson EJ, Albers JW. Neurological manifestations of porphyria. In: Aminoff MJ, Boller F, Swaab DF (ed.). Handbook of Clinical Neurology, Vol. 70. Amsterdam: Elsevier, 1998; 299-312.
10. Shun CT, Chang YC, Wu HP et al. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain 2004; 127: 1593-1605.
11. Hilz MJ, Axelrod FB, Bickel A et al. Assessing function and pathology in familial dysautonomia: assessment of temperature perception, sweating and cutaneous innervation. Brain 2004; 127: 2090-2098.
12. Chiang MC, Lin YH, Pan CL et al. Cutaneous innervation in chronic inflammatory demyelinating polyneuropathy. Neurology 2002; 59: 1094-1098.
13. Li J, Bai Y, Ghandour K et al. Skin biopsies in myelinrelated neuropathies: bringing molecular pathology to the bedside. Brain 2005; 128: 1168-1177.
14. Pan CL, Tseng TJ, Lin YH, Chiang MC, Lin WM, Hsieh ST. Cutaneous innervation in Guillain-Barre syndrome: pathology and clinical correlations. Brain 2003; 126: 386-397.
15. Smith AG, Howard JR, Kroll R et al. The reliability of skin biopsy with measurement of intraepidermal nerve fiber density. J Neurol Sci 2005; 228: 65-69.
16. Hsieh ST, Chiang HY, Lin WM. Pathology of nerve terminal degeneration in the skin. J Neuropathol Exp Neurol 2000; 59: 297-307.
17. Kauppinen R. Porphyrias. Lancet 2005; 365: 241-252.
18. Pischik E, Bulyanitsa A, Kazakov V, Kauppinen R. Clinical features predictive of a poor prognosis in acute porphyria. J Neurol 2004; 251: 1538-1541.
19. Crimlisk HL. The little imitator - porphyria: a neuropsychiatric disorder. J Neurol Neurosurg Psychiatry 1997; 62: 319-328.
20. Polydefkis M, Yiannoutsos CT, Cohen BA et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 2002; 58: 115-119.
21. Santiago S, Espinosa ML, Perez-Conde MC, Merino M, Ferrer T. Small fiber dysfunction in peripheral neuropathies. Rev Neurol 1999; 28: 543-554.
22. Kauppinen R, von und zu Fraunberg M. Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families. Clin Chem 2002; 48: 1891-1900.
23. von und zu Fraunberg M, Pischik E, Udd L, Kauppinen R. Clinical and biochemical characteristics and genotype-phenotype correlation in 143 Finnish and Russian patients with acute intermittent porphyria. Medicine (Baltimore) 2005; 84: 35-47.
24. Ko MH, Chen WP, Lin-Shiau SY, Hsieh ST. Age-dependent acrylamide neurotoxicity in mice: morphology, physiology, and function. Exp Neurol 1999; 158: 37-46.
25. Verdu E, Vilches JJ, Rodriguez FJ, Ceballos D, Valero A, Navarro X. Physiological and immunohistochemical characterization of cisplatin-induced neuropathy in mice. Muscle Nerve 1999; 22: 329-340.
26. Albers JW, Robertson WC Jr, Daube JR. Electrodiagnostic findings in acute porphyric neuropathy. Muscle Nerve 1978; 1: 292-296.
27. Periasamy V, al Shubaili A, Girsh Y. Diagnostic dilemmas in acute intermittent porphyria. A case report. Med Princ Pract 2002; 11: 108-111.
28. McArthur JC, Yiannoutsos C, Simpson DM et al. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291. Neurology 2000; 54: 1080-1088.